EUR 0.3
(-2.6%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.03 EUR | 176.04% |
2022 | -0.04 EUR | 45.69% |
2021 | -0.07 EUR | 69.95% |
2020 | -0.22 EUR | 15.38% |
2019 | -0.26 EUR | 38.1% |
2018 | -0.42 EUR | -2796.55% |
2017 | -0.01 EUR | 93.41% |
2016 | -0.22 EUR | -425.06% |
2015 | -0.04 EUR | -115.52% |
2014 | 0.27 EUR | 145.45% |
2013 | 0.11 EUR | 234.8% |
2012 | -0.08 EUR | 0.0% |
2011 | - EUR | -100.0% |
2010 | 0.13 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 FY | - EUR | 176.04% |
2023 Q2 | 0.03 EUR | 0.0% |
2023 Q3 | -0.01 EUR | -146.48% |
2023 Q1 | 0.03 EUR | 724.39% |
2023 Q4 | -0.01 EUR | 0.0% |
2022 FY | - EUR | 45.69% |
2022 Q4 | -0.00 EUR | 0.0% |
2021 FY | - EUR | 69.95% |
2020 FY | - EUR | 15.38% |
2019 FY | - EUR | 38.1% |
2018 FY | - EUR | -2796.55% |
2017 FY | - EUR | 93.41% |
2016 FY | - EUR | -425.06% |
2015 FY | - EUR | -115.52% |
2014 FY | - EUR | 145.45% |
2013 FY | - EUR | 234.8% |
2012 FY | - EUR | 0.0% |
2011 FY | - EUR | -100.0% |
2010 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Atrys Health, S.A. | -0.60 EUR | 104.55% |
Oryzon Genomics S.A. | -0.06 EUR | 149.546% |
Pharma Mar, S.A. | 0.06 EUR | 57.008% |
Laboratorios Farmaceuticos Rovi, S.A. | 3.29 EUR | 99.17% |